Skip to Content
MDPIMDPI

2 Results Found

  • Article
  • Open Access
24 Citations
14,588 Views
10 Pages
Download PDF

Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study

  • Daniel Keizman,
  • Moshe Frenkel,
  • Avivit Peer,
  • Igal Kushnir,
  • Eli Rosenbaum,
  • David Sarid,
  • Ilan Leibovitch,
  • Roy Mano,
  • Ofer Yossepowitch and
  • Isaac Eliaz
  • + 6 authors
Nutrients2021, 13(12), 4295;https://doi.org/10.3390/nu13124295

28 November 2021

Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol®, P-MCP), a dietary polysaccharide, is an established antagonist of galectin-3, a carbohydrate-bind...

(This article belongs to the Section Phytochemicals and Human Health)
Full Article
  • Review
  • Open Access
108 Citations
27,269 Views
18 Pages
Download PDF

Pleiotropic Effects of Modified Citrus Pectin

  • Isaac Eliaz and
  • Avraham Raz
Nutrients2019, 11(11), 2619;https://doi.org/10.3390/nu11112619

1 November 2019

Modified citrus pectin (MCP) has a low-molecular-weight degree of esterification to allow absorption from the small intestinal epithelium into the circulation. MCP produces pleiotropic effects, including but not limited to its antagonism of galectin-...

Full Article